Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROE

Share:
Related VIVO
15 Biggest Mid-Day Losers For Wednesday
Mid-Afternoon Market Update: Seagate Climbs On Strong Q2 Results; Meridian Bioscience Shares Plummet
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those ... (GuruFocus)
Related NEOG
Earnings Scheduled For September 19, 2017
Benzinga's Top Upgrades, Downgrades For July 14, 2017

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the same period is $171.20 million.

The trailing-twelve-month return on equity at Neogen (NASDAQ: NEOG) is 10.90%. Neogen's operating margin for the same period is 18.46%.

The trailing-twelve-month return on equity at Trinity Biotech plc (NASDAQ: TRIB) is 10.77%. Trinity Biotech's profit margin for the same period is 20.71%.

The trailing-twelve-month return on equity at Abaxis (NASDAQ: ABAX) is 8.20%. Abaxis' PEG ratio is 2.69.

Posted-In: Diagnostic Substances Industry highest ROE small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

View Comments and Join the Discussion!

Partner Center